Skip to content

Unmet Needs in Psoriasis

The concept of unmet needs in psoriasis is not new. We are aware that both patients and physicians feel there are gaps in the management and treatment of the condition. Here we review unmet needs with current therapies for psoriasis. Biologics interleukin-17 blockers interleukin-23 blockers psoriasis Psoriasis Area and Severity Index secukinumab. Discover the Unmet Need in Psoriatic Arthritis. The National Psoriasis Foundation conducts biannual surveys to identify undertreatment, treatment trends, and treatment satisfaction among patients with psoriasis and psoriatic arthritis.

Unmet Needs in Psoriasis 2This study set out to find the unmet needs of psoriasis & psoriatic arthritis patients, and concluded there are several identified unmet needs that warrant additional attention and action. Learn about the unmet needs of patients with psoriasis and psoriatic arthritis, including quality of life issues and treatment barriers from the MAPP (Multinational Assessment of Psoriasis and Psoriatic Arthritis) survey. Dermatologists reveal that most psoriasis patients in the US, Japan, and five major EU markets receive pharmacologic therapy, whether in combination with non-drug therapy or on its own. This is unsurprising and mirrors treatment guidelines for psoriasis. What current unmet needs exist within psoriasis?

Although a number of treatment options exist for PsO, there continue to be significant unmet needs in the market. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity on ResearchGate, the professional network for scientists. The International Federation of Psoriasis Associations (IFPA) is a non-profit organization made up of psoriasis associations from around the world.

Understanding Unmet Needs Of Psoriasis Patients

Unmet Needs in Psoriasis 3The briefing will highlight the unique challenges facing people of color with psoriasis, as well as the unmet needs of the entire psoriatic disease community.

2015: A Good Year For Psoriasis Drug Development?